SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
180GS: EXEL(IL/N): Missed Q2 on lower revs. Revised 2005-07 est. Q2 transactions shmopgcw-8/22/2005
179Good idea. 10-13 cpds in clinical development by YE06. If just 2 show clinicalkeokalani'nui-8/17/2005
178EXEL discusses PII strategies: >>SOUTH SAN FRANCISCO, Calif., Aug. 15 /PRtuck-8/15/2005
177Exelixis Announces Second Quarter 2005 Financial Results Monday August 8, 4:00 pmopgcw-8/8/2005
176Interim look at NVS/SGP ptk787 shows it unlikely to increase survival in advancekeokalani'nui-7/28/2005
175Artemis Pharmaceuticals and Taconic Form Strategic Alliance for Generation and Mscaram(o)uche-6/20/2005
174A little snip re: EXEL at the bottom. Bad News About Biotech Funds Dr. Scott GLJM-6/17/2005
173GS: EXEL(IL/N): Two agreements to increase capital and focus on proprietary compmopgcw-6/15/2005
172>>Be interesting to see if they can keep pumping out the NCEs.<< Yekeokalani'nui-6/14/2005
171Agree entirely - new drugs into patients, asap, and do whatever it takes to raisnigel bates-6/14/2005
170No matter what you think about exel's prospects, these guys are working theikeokalani'nui-6/14/2005
169Exelixis Files IND Application for Anticancer Compound XL184 Tuesday June 14, 6:nigel bates-6/14/2005
168Piper: This morning, Exelixis announced a new collaboration agreement with Genemopgcw-6/14/2005
167>> rkrw will probably now post << rkrw is one of the very best of bscaram(o)uche-6/13/2005
166It will all depend on what they're spending their money on. I do expect gsrkrw-6/13/2005
165LOL, you’re such a sucker for these kinds of deals. I doubt EXEL will ever againDewDiligence_on_SI-6/13/2005
164LOLnigel bates-6/13/2005
163<<rkrw will probably now post saying what a great transaction it is for thrkrw-6/13/2005
162Will have to listen to the call. But exel has said in the past gsk has upped somrkrw-6/13/2005
161<i>...Exelixis intends to consolidate the financial results of Symphony Evnigel bates-6/13/2005
160Another reason to avoid investing in EXEL, IMHO. rkrw will probably now post sDewDiligence_on_SI-6/13/2005
159Exelixis Seeks to Raise Cash Using 3 of Its Top Drug Candidates By DAVID P. HAMDoc Bones-6/13/2005
158Exelixis Announces Transaction to Fund Clinical Development for XL647, XL999 andscaram(o)uche-6/13/2005
157Sophisticated commentary from Forbes.... <i>Exelixis-Genentech Pact Seen nigel bates-6/3/2005
156Exelixis and Genentech Collaborate on Novel Therapeutics for Cancer, Inflammationigel bates-6/3/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News